Activation of the Antiviral Prodrug Oseltamivir Is Impaired by Two Newly Identified Carboxylesterase 1 Variants
Authors:
- Hao-Jie ZhuHZHao-Jie Zhu
- John S. MarkowitzJMJohn S. Markowitz
- 1 February 2009
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 37 (2) , 264-267
Abstract
Oseltamivir phosphate is an ethyl ester prodrug widely used in the treatment and prevention of both Influenzavirus A and B infections. The conversion of oseltamivir to its active metabolite oseltamivir carboxylate is dependent on ester hydrolysis mediated by carboxylesterase 1 (CES1). We recently identified two functional CES1 variants p.Gly143Glu and p.Asp260fs in a research subject who displayed significant impairment in his ability to metabolize the selective CES1 substrate, methylphenidate. In vitro functional studies demonstrated that the presence of either of the two mutations can result in severe reductions in the catalytic efficiency of CES1 toward methylphenidate, which is required for hydrolysis and pharmacological deactivation. The aim of the present study was to investigate the function of these mutations on activating (hydrolyzing) oseltamivir to oseltamivir carboxylate using the cell lines expressing wild type (WT) and each mutant CES1. In vitro incubation studies demonstrated that the S9 fractions prepared from the cells transfected with WT CES1 and human liver tissues rapidly convert oseltamivir to oseltamivir carboxylate. However, the catalytic activity of the mutant hydrolases was dramatically hindered. The Vmax value of p.Gly143Glu was approximately 25% of that of WT enzyme, whereas the catalytic activity of p.Asp260fs was negligible. These results suggest that the therapeutic efficacy of oseltamivir could be compromised in treated patients expressing either functional CES1 mutation. Furthermore, the potential for increased adverse effects or toxicity as a result of exposure to high concentrations of the nonhydrolyzed prodrug should be considered.Keywords
This publication has 19 references indexed in Scilit:
- Structural Organization and Characterization of the Regulatory Element of the Human Carboxylesterase (CES1A1 and CES1A2) genesDrug Metabolism and Pharmacokinetics, 2008
- Substrate Specificity of Carboxylesterase Isozymes and Their Contribution to Hydrolase Activity in Human Liver and Small IntestineDrug Metabolism and Disposition, 2006
- ONTOGENY OF HEPATIC AND PLASMA METABOLISM OF DELTAMETHRIN IN VITRO: ROLE IN AGE-DEPENDENT ACUTE NEUROTOXICITYDrug Metabolism and Disposition, 2006
- IDENTIFICATION OF ESTERASES EXPRESSED IN CACO-2 CELLS AND EFFECTS OF THEIR HYDROLYZING ACTIVITY IN PREDICTING HUMAN INTESTINAL ABSORPTIONDrug Metabolism and Disposition, 2005
- A Single Nucleotide Polymorphism in the Carboxylesterase Gene Is Associated with the Responsiveness to Imidapril Medication and the Promoter ActivityHypertension Research, 2005
- FURTHER ASSESSMENT OF ANIN VITROSCREEN THAT MAY HELP IDENTIFY ORGANOPHOSPHORUS PESTICIDES THAT ARE MORE ACUTELY TOXIC TO THE YOUNGJournal of Toxicology and Environmental Health, Part A, 2004
- Carboxylesterase and A-Esterase Activities during Maturation and Aging: Relationship to the Toxicity of Chlorpyrifos and Parathion in RatsToxicological Sciences, 2000
- Age- and Gender-Related Differences in Sensitivity to Chlorpyrifos in the Rat Reflect Developmental Profiles of Esterase ActivitiesToxicological Sciences, 1998
- Regulation of Two Rat-Liver Microsomal Carboxylesterase Isozymes - Species-Differences, Tissue Distribution, and the Effects of Age, Sex, and Xenobiotic Treatment of RatsArchives of Biochemistry and Biophysics, 1994
- Esterase-1: Developmental expression in the mouse and distribution of related proteins in other speciesArchives of Biochemistry and Biophysics, 1992